The present invention relates to 2-(benzoylamino)benzoic acid derivatives of the formula I wherein the variants Ar, X and R are as described in the specification. The said compounds modulate the activity of peroxisome proliferator-activated receptors (PPAR) α and/or γ, and are predicted to be useful in the treatment of metabolic diseases, e.g. type II diabetes.
-
(2008/06/13)
More Articles about upstream products of 485824-40-6